Surrey Technology Centre
40 Occam Road
Guildford GU2 7YG
United Kingdom
44 14 8368 5670
https://www.futuramedical.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 12
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. James Henry Barder | CEO & Exec. Director | 491.79k | N/A | 1960 |
Ms. Angela Hildreth | COO, Fin. Director, Company Sec. & Exec. Director | 384.92k | N/A | N/A |
Mr. Kenneth William James | Head of R&D & Exec. Director | 352.47k | N/A | 1953 |
Dr. William Duncan Potter | Chief Scientific Officer & Adviser to the Board | N/A | N/A | 1948 |
Graham Smith | Head of Alliance Partnerships & Supply | N/A | N/A | N/A |
Kevin Langridge | Head of Quality | N/A | N/A | N/A |
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Futura Medical plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.